- Home
- CRNX vs GLBS Comparison
CRNX vs GLBS Comparison
Compare CRNX & GLBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- GLBS
- Stock Information
- Founded
- CRNX 2008
- GLBS 2006
- Country
- CRNX United States
- GLBS Greece
- Employees
- CRNX N/A
- GLBS N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- GLBS Marine Transportation
- Sector
- CRNX Health Care
- GLBS Consumer Discretionary
- Exchange
- CRNX Nasdaq
- GLBS Nasdaq
- Market Cap
- CRNX 2.8B
- GLBS N/A
- IPO Year
- CRNX 2018
- GLBS 2007
- Fundamental
- Price
- CRNX $30.51
- GLBS $1.08
- Analyst Decision
- CRNX Strong Buy
- GLBS
- Analyst Count
- CRNX 10
- GLBS 0
- Target Price
- CRNX $75.00
- GLBS N/A
- AVG Volume (30 Days)
- CRNX 942.0K
- GLBS 20.6K
- Earning Date
- CRNX 05-08-2025
- GLBS 06-13-2025
- Dividend Yield
- CRNX N/A
- GLBS N/A
- EPS Growth
- CRNX N/A
- GLBS N/A
- EPS
- CRNX N/A
- GLBS 0.02
- Revenue
- CRNX $760,000.00
- GLBS $34,870,000.00
- Revenue This Year
- CRNX $343.70
- GLBS $33.39
- Revenue Next Year
- CRNX $733.93
- GLBS $22.81
- P/E Ratio
- CRNX N/A
- GLBS $51.58
- Revenue Growth
- CRNX N/A
- GLBS 11.74
- 52 Week Low
- CRNX $24.10
- GLBS $0.99
- 52 Week High
- CRNX $62.53
- GLBS $2.35
- Technical
- Relative Strength Index (RSI)
- CRNX 46.97
- GLBS 48.31
- Support Level
- CRNX $29.05
- GLBS $0.99
- Resistance Level
- CRNX $30.99
- GLBS $1.15
- Average True Range (ATR)
- CRNX 1.43
- GLBS 0.05
- MACD
- CRNX -0.09
- GLBS 0.01
- Stochastic Oscillator
- CRNX 32.27
- GLBS 42.86
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.